Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Elevation Oncology Inc (ELEV)

Elevation Oncology Inc (ELEV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Elevation Oncology Inc 101 Federal Street Suite 1900 Boston MA 02110 USA

www.elevationoncology.com P: 716-371-1125

Description:

Elevation Oncology Inc. is a clinical stage biopharmaceutical company. It focused on the development of precision medicines for patients with genomically defined cancers. Elevation Oncology Inc. is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 202,161
Enterprise Value, $K 183,041
Shares Outstanding, K 54,638
Annual Sales, $ 0 K
Annual Net Income, $ -45,700 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,900 K
EBIT, $ -45,450 K
EBITDA, $ -46,270 K
60-Month Beta 1.52
% of Insider Shareholders 14.90%
% of Institutional Shareholders 83.70%
Float, K 46,497
% Float 85.10%
Short Volume Ratio 0.30

Growth:

1-Year Return -5.32%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 03/06/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -1.31
EPS Growth vs. Prev Qtr -21.05%
EPS Growth vs. Prev Year 54.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ELEV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -62.33%
Return-on-Assets % -39.43%
Profit Margin % 0.00%
Debt/Equity 0.55
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.96
Book Value/Share 1.29
Interest Coverage -1.28
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar